Visit TheBody.com for Patient Education
You are not currently logged in. Login or Register



Sign up for free e-mail/fax newsletters!

Home All Topics Newsroom Conferences JournalView Clinical Management CME/CE Ask Your Colleagues

Now Live: Breaking Research From XVII International AIDS Conference >>

    BROWSE TOPICS IN CLINICAL MANAGEMENT:
  • Antiretroviral Therapy
  • Antiretroviral Therapy
    • Acute Infection
    • Antiretrovirals
    • Assays (Diagnostic & Monitoring)
    • Guidelines
    • Initial Therapy
    • Pediatrics
    • Resistance
    • Salvage Therapy
    • Second/Third-Line Treatment
    • Structured Treatment Interruptions
    • Women & Pregnancy
    • More ...
  • Complications of HIV/HAART
  • Complications of HIV/HAART
    • Overview
    • Cardiovascular
    • Lipoatrophy
    • Gastrointestinal
    • Hepatitis
    • HPV & Cervical/Anal Cancer
    • Liver Complications
    • Malignancies
    • Mental Health
    • Metabolic
    • Neurocognitive
    • Renal Complications
    • Women-Specific
    • More ...
  • Research & Development
  • Research & Development
    • Overview
    • Antiretrovirals in Development
    • Conference Reports
    • HIV Genetics
    • HIV Immunology
    • More ...
  • Clinical Trials
  • Clinical Trials
    • Overview & News
    • U.S. Databases
    • U.S. Nationwide Studies
    • U.S. State-by-State Trial Listings
    • Databases Outside U.S.
    • Specific Trials Outside U.S.
    • More ...
  • Quality of Life & Patient Care
  • Quality of Life & Patient Care
    • Complementary Medicine
    • Mental Health
    • Primary Care
Failed Antiretrovirals

Overview | Capravirine | DAPD (Amdoxovir) | Lodenosine | T-1249
Overview
  • Failed Anti-HIV Drugs (Regularly Updated)
    From aidsmap.com

Capravirine
  • A Clinical Overview of Capravirine (Regularly Updated)
    To read PDF, click here
    From U.S. National Institutes of Health

  • Pfizer Drops Development of Antiretroviral Capravirine, Citing Lack of Efficacy in Trials (July 5, 2005)
    In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation

  • Pfizer Discontinues Development of Capravirine, for HIV/AIDS (July 1, 2005)
    From Pfizer, Inc.

Othe Drugs
  • Incyte Halts Development of Promising New CCR5 Drug (April 10, 2008)
    From Project Inform

  • GSK Discontinues Clinical Development of Investigational Protease Inhibitor Brecanavir (640385) (December 18, 2006)
    To read PDF, click here
    From GlaxoSmithKline

  • Development of DFC, an Investigational NRTI, Is Discontinued (April 4, 2006)
    From The Body


global Toolbox

Contact Us | Privacy Policy

The Body PRO is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body PRO and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body PRO's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body PRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body PRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.